Implementing an earlier and more intensive follow-up in acute heart failure: the STRONG-HF and COACH trials

Affiliations

¹ Centre for Clinical and Basic Research, IRCCS San Raffaele, Rome, Italy. giuseppe.rosano@gmail.com.
² Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Comment

Giuseppe M C Rosano et al. Nat Rev Cardiol. 2023 Apr.

. 2023 Apr;20(4):213-214.

doi: 10.1038/s41569-023-00841-x.

¹ Centre for Clinical and Basic Research, IRCCS San Raffaele, Rome, Italy. giuseppe.rosano@gmail.com.
² Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

No abstract available

Comment on

Trial of an Intervention to Improve Acute Heart Failure Outcomes.
Lee DS, Straus SE, Farkouh ME, Austin PC, Taljaard M, Chong A, Fahim C, Poon S, Cram P, Smith S, McKelvie RS, Porepa L, Hartleib M, Mitoff P, Iwanochko RM, MacDougall A, Shadowitz S, Abrams H, Elbarasi E, Fang J, Udell JA, Schull MJ, Mak S, Ross HJ; COACH Trial Investigators. Lee DS, et al. N Engl J Med. 2023 Jan 5;388(1):22-32. doi: 10.1056/NEJMoa2211680. Epub 2022 Nov 5. N Engl J Med. 2023. PMID: 36342109 Clinical Trial.
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.
Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, Metra M, Ponikowski P, Sliwa K, Voors AA, Edwards C, Novosadova M, Takagi K, Damasceno A, Saidu H, Gayat E, Pang PS, Celutkiene J, Cotter G. Mebazaa A, et al. Lancet. 2022 Dec 3;400(10367):1938-1952. doi: 10.1016/S0140-6736(22)02076-1. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356631 Clinical Trial.

1. Savarese, G. et al. Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF). JACC Heart Fail. 11, 1–14 (2023). - DOI - PubMed
1. McDonagh, T. A. et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 42, 3599–3726 (2021). - DOI - PubMed
1. Heidenreich, P. A. et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 79, 1757–1780 (2022). - DOI - PubMed
1. Mebazaa, A. et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet 400, 1938–1952 (2022). - DOI - PubMed
1. Stolfo, D. et al. Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata. Eur. J. Heart Fail. 24, 1047–1062 (2022). - DOI - PubMed